Dr. Barry Dworkin

Two-year cancer-DNA-fragment screening blood test trial to start in England to assess sensitivity and specificity of early detection of numerous cancer types. If successful, it could lead to treatment of once difficult-to-detect early cancers.

Medical Mythbusting Commentary for September 20, 2021

Source:
World’s Largest Trial Of “Game-Changer” Early Cancer Test Begins In UK

Related posts:

  1. New diagnostic, screening and disease-tracking technologies show promise
  2. Genetic test for prostate cancer recurrence can help personalize care and management
  3. Proof-of-concept blood test that screens for certain cancers shows promise
  4. AstraZeneca is soon to publish results from its pre-exposure prophylaxis trial about anti-Covid antibodies given IM to people with comorbid states that reduce the immune response from vaccines. Reduced severe symptomatic risk (relative) by 77%.